PacBio Reports 18 Percent Q2 Revenue Drop, Books Seven Systems Orders | GenomeWeb

NEW YORK (GenomeWeb News) – Pacific Biosciences reported after the close of market on Thursday that while its second quarter 2013 revenues dropped roughly 18 percent year over year, its revenues grew 7 percent sequentially.

The Menlo Park, Calif.-based single-molecule sequencing technologies firm reported total revenues of $6 million for the three months ended June 30, compared to $7.3 million in the second quarter of 2012, and $5.6 million in the first quarter of 2013. It fell just shy of the consensus Wall Street estimate for revenues of $6.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.